Spero Therapeutics, Inc.
Spero Therapeutics, Inc.（SPRO）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
spro · 股价预测 · 13 位分析师（近3月）· FMP · 更新于 2026年6月9日
分析师评级与共识
基于过去 3 个月内 13 位华尔街分析师
Buy
13 位分析师
共识
评级分布
12 个月目标价
High
$0.00
Consensus
$0.00
+0.0% upside
Low
$0.00
Median: $0 · Last Close: $2.74
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $2.80 | ↑ 2.23% |
1-day model range: $2.78–$2.82. Peak: $2.82 (+2.23%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $3 | +20.2% |
| 2028 | $4 | +32.3% |
| 2029 | $4 | +39.0% |
| 2030 | $4 | +42.5% |
| 2031 | — | +44.3% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · SPRO · Jun 9, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2025-01-30 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-12-20 | Evercore ISI Group | Downgrade ↓ | Outperform→In Line |
| 2024-12-02 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-11-18 | TD Cowen | Downgrade ↓ | Buy→Hold |
| 2024-11-04 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-10-03 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-08-06 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-08-06 | TD Cowen | Upgrade ↑ | Hold→Buy |
| 2024-05-16 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-03-18 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Spero Therapeutics, Inc. (SPRO) stock. Of the recent 43 rating actions, 2 were upgrades and 8 were downgrades. 13 analysts currently cover SPRO.
分析师推荐趋势
SPRO analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$26M
↑ 696.9% YoY
Revenue Next Year
$1M
↓ 96.9% YoY
EPS This Year
$-0.10
EPS Next Year
$0.67
↓ 770.0% YoY
EPS ForecastReported vs Estimated
Analysts forecast SPRO EPS of $-0.10 for the current fiscal year, based on estimates from 1 analysts. The SPRO revenue forecast is $26M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
SPRO 股价预测由两类独立数据源支撑：来自 13 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。SPRO 的共识目标价为 $0.00（+0.0% 上行空间），分析师共识为 Buy。
SPRO 的短期预测（明日）为 $2.80（+2.23%）。 SPRO 对 2027 年的股价预测均值为 $3。 SPRO 对 2030 年的预测区间为 $4–$4。
Spero Therapeutics, Inc. 在 NASDAQ 上市，代码 SPRO。SPRO 在 2027 年的整体展望偏积极，在覆盖分析师中约 46% 对应 Buy 共识。
常见问题
SPRO 预测 · 8 个问题根据 13 位华尔街分析师，SPRO 的 12 个月平均目标价为 $0.00，最高 $0.00、最低 $0.00。若有图表，中位目标价可在上方查看。相对当前价 $2.74，隐含约 +0.0% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.